Medical SpecialtyOpen Access

Evaluation of constipation seriousness scale in sglt 2 inhibitor users

Is this your thesis?

This record came from a bulk archive import. If it’s yours, link it to your profile.

2025
0 views
0 downloads

Abstract (EN)

Objective: It was aimed to evaluate the effect of SGLT2 inhibitors, one of the antidiabetic drugs in DM treatment, on constipation using a scale on the day of treatment and 3 months later. Materials and Methods: Our study included 61 patients who were admitted to the Department of Internal Medicine at Süleyman Demirel University Research and Training Hospital and were followed up with a diagnosis of diabetes and were planned to start SGLT2 inhibitors. The questionnaire was applied twice, on the day the SGLT2 inhibitor was planned to be started and 3 months later. Data were transferred to IBM SPSS.25 (IBM Inc. , Chicago, IL, USA) program and evaluated with statistical analyses. In all analyses, p<0.05 was accepted as the significance level. Results: Patients 40 of them were male and 21 were female. In our study, a significant decrease was observed in fecal obstruction, colon laziness and pain levels compared to the initial values (p<0.05). While the total score was 5.79 at the beginning, it decreased to 3.30 at the last measurement and this decrease was statistically significant (p<0.001). A significant decrease was observed in the mean total score in both genders. Conclusion: The effect of SGLT2 inhibitors on constipation was evaluated. While a significant decrease was observed in the mean fecal obstruction in men over time, the decrease in women was not found to be significant. A significant decrease was obtained in the mean colonic inertia in both genders. While a significant decrease in mean pain was seen in women, the decrease in mean pain in men was not significant. A significant decrease in the total mean score was observed in both genders.

Author

Aişe Duran Canbulut

How to Cite

Aişe Duran Canbulut (Medical Specialty Thesis). Evaluation of constipation seriousness scale in sglt 2 inhibitor users, 2025, Süleyman Demirel University.

Keywords

License

Tüm Hakları Saklıdır

This work is shared under the specified license terms.

More theses from Süleyman Demirel University